Lipoprotein lipase correlates positively and hepatic lipase inversely with calcific atherosclerosis in homozygous familial hypercholesterolemia

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 2, 1997, Pages 354-364

  Dugi, Klaus A ^b   Feuerstein, Irwin M ^a   Hill, Suvimol ^a   Shih, Joanna ^b   Santamarina Fojo, Silvia ^b   Brewer Jr , H Bryan ^b   Hoeg, Jeffrey M ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

atherosclerosis; computed tomography x ray; coronary disease; macrophages; xanthomatosis

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN LIPASE; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CALCIFICATION; CHILD; CLINICAL ARTICLE; CORONARY ARTERY; ENZYME ANALYSIS; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; RECEPTOR AFFINITY; RISK FACTOR;

EID: 0031033099     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.2.354     Document Type: Article

References (21)

1. Goldstein JL, Hobbs HH, Brown MS. Familial hypercholesterolemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. New York, NY: McGraw-Hill, Inc; 1995:1981-2030.
2. Hoeg JM. Familial hypercholesterolemia: what the zebra can teach us about the horse. JAMA. 1994;271:543-546.
3. Sprecher DL, Hoeg JM, Schaefer EJ, Zech LA, Gregg RE, Lakatos E, Brewer HB Jr. The association of LDL receptor activity, LDL cholesterol level, and clinical course in homozygous familial hypercholesterolemia. Metabolism. 1985;34:294-299.
4. Sprecher DL, Schaefer EJ, Kent KM, Gregg RE, Zech LA, Hoeg JM, McManus B, Roberts WC, Brewer HB Jr. Cardiovascular features of homozygous familial hypercholesterolemia: analysis of 16 patients. Am J Cardiol. 1984;54:20-30.
5. Goldstein JL. The cardiac manifestations of the homozygous and heterozygous forms of familial type II hyperbetalipoproteinemia. Birth Defects. 1972;8:202-208.
6. Hobbs HH, Brown MS, Russell DW, Davignon J, Goldstein JL. Deletion in LDL receptor gene occurs in majority of French Canadians with familial hypercholesterolemia. N Engl J Med. 1987;317:734-737.
7. Brunzell JD. Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. New York, NY: McGraw-Hill, Inc; 1995:1913-1932.
8. Santamarina-Fojo S, Dugi K. Structure, function and role of lipoprotein lipase in lipoprotein metabolism. Curr Opin Lipidol. 1994;5:117-125.
9. Nikkilä EA, Taskinen MR, Kekki M. Relation of plasma high-density lipoprotein cholesterol to lipoprotein-lipase activity in adipose tissue and skeletal muscle of man. Atherosclerosis. 1978;29:497-501.
10. Magill P, Rao SN, Miller NE, Nicoll A, Brunzell J, St. Hilaire J, Lewis B. Relationships between the metabolism of high-density and very-low-density lipoproteins in man: studies of apolipoprotein kinetics and adipose tissue lipoprotein lipase activity. Eur J Clin Invest. 1982;12:113-120.
11. Taskinen MR. Lipoprotein lipase in hypertriglyceridemias. In: Borensztajn J, ed. Lipoprotein Lipase. Chicago, III: Evener Publishers; 1987:201-228.
12. Shimada M, Shimano H, Gotoda T, Yamamoto K, Kawamura M, Inaba T, Yazaki Y, Yamada N. Overexpression of human lipoprotein lipase in transgenic mice. J Biol Chem. 1993;268:17924-17929.
13. Liu M-S, Jirik FR, LeBoeuf RC, Henderson H, Castellani LW, Lusis AJ, Ma Y, Forsythe IJ, Zhang H, Kirk E, Brunzell JD, Hayden MR. Alteration of lipid profiles in plasma of transgenic mice expressing human lipoprotein lipase. J Biol Chem. 1994;269:11417-11424.
14. Zsigmond E, Scheffler E, Forte TM, Potenz R, Wu W, Chan L. Transgenic mice expressing human lipoprotein lipase driven by the mouse metallothionein promoter. J Biol Chem. 1994;269:18757-18766.
15. Tsutsumi K, Inoue Y, Shima A, Iwasaki K, Kawamura M, Murase T. The novel compound NO-1886 increases lipoprotein lipase activity with resulting elevation of high density lipoprotein cholesterol, and long-term administration inhibits atherogenesis in the coronary arteries of rats with experimental atherosclerosis. J Clin Invest. 1993;92:411-417.
16. Zilversmit DB. A proposal linking atherogenesis to the interaction of endothelial lipoprotein lipase with triglyceride-rich lipoproteins. Circ Res. 1973;33:633-638.
17. Zilversmit DB. Atherogenesis: a postprandial phenomenon. Circulation. 1979;60:473-485.
18. Herttuala SY, Lipton BA, Rosenfeld ME, Goldberg LJ, Steinberg D, Witztum JL. Macrophages and smooth muscle cells express lipoprotein lipase in human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA. 1991;88:10143-10147.
19. O'Brien KD, Gordon D, Deeb S, Ferguson M, Chait A. Lipoprotein lipase is synthesized by macrophage-derived foam cells in human coronary atherosclerotic plaques. J Clin Invest. 1992;89:1544-1550.
20. Saxena U, Kulkarni NM, Ferguson E, Newton RS. Lipoprotein lipase-mediated lipolysis of very low density lipoproteins increases monocyte adhesion to aortic endothelial cells. Biochem Biophys Res Commun. 1992;189:1653-1658.
21. Saxena U, Klein MG, Vanni TM, Goldberg IJ. Lipoprotein lipase increases low density lipoprotein retention by subendothelial cell matrix. J Clin Invest. 1992;89:373-380.